Claire Mazumdar

Claire Mazumdar currently serves as the Chief Executive Officer at Bicara Therapeutics since January 2020 and holds a position as a Member of the Board of Directors at Noora Health since January 2022. Prior experience includes roles in Business Development & Corporate Strategy at Rheos Medicines from March 2018 to January 2020 and as a Senior Associate at Third Rock Ventures from July 2017 to July 2019. Claire Mazumdar holds a Master of Business Administration (M.B.A.) from Stanford University Graduate School of Business, a Doctor of Philosophy (Ph.D.) in Cancer Biology from Stanford University School of Medicine, and a Bachelor of Science (B.S.) in Biological Engineering from the Massachusetts Institute of Technology.